Additional information
| Active substance | Letrozole | 
|---|---|
| Raw Material | Letrozole | 
| Active Half-Life | 2-3 days | 
| Classification | Non-steroidal aromatase inhibitor | 
| Dosage | 0.5-1 mg throughout 1 to 3 days | 
| Acne | No | 
| Water Retention | No | 
| HBR | No | 
| Hepatotoxicity | No | 
| Aromatization | No | 
| Lab Test | Monitoring of liver function tests, lipid profiles, and bone density | 
| Also known as | Letrozol | 
| Blood pressure | Can cause a decrease in blood pressure | 
| Trade name | Femara | 
| Storage conditions | Store at room temperature away from moisture and heat | 
| Chemical name | 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile | 
| Formula | C17H11N5 | 
| Substance class | Aromatase inhibitor | 
| Main action | Inhibits the enzyme aromatase, preventing the synthesis of estrogen | 
| Half-life | 2 days | 
| Dosage (medical) | 2.5 mg daily | 
| Dosage (sports) | Typically 0.5 mg to 2.5 mg daily depending on purpose and cycling needs | 
| Effects | Reduces estrogen levels, increases luteinizing hormone and follicle-stimulating hormone levels | 
| Side effects | Hot flashes, joint pain, fatigue, increased risk of osteoporosis, nausea | 
| Use in sports | Used by bodybuilders and athletes to reduce estrogen levels and increase testosterone levels | 
| Manufacturer | XENO LABS INT | 
| Packing | 30 tabs (2.5 mg/tab) | 
 Balkan Pharma Strombafort 10 mg 60 Tabletten
							Balkan Pharma Strombafort 10 mg 60 Tabletten						 Letrodex Sciroxx
							Letrodex Sciroxx						 FEMAMED 2.5 DEUS MEDICAL
							FEMAMED 2.5 DEUS MEDICAL						

 
			 
			 
			
Reviews
There are no reviews yet.